U-BIOPRED队列中口服糖皮质激素的重症哮喘患者用药依从性
本研究基于U-BIOPRED队列中166例每日口服糖皮质激素的重症哮喘患者,采用自报量表与尿液药物检测两种方法评估依从性。37%自报依从性不佳,43%尿液检测未检出泼尼松龙或其代谢物,两种方法检测结果不一致率达53%。自报高依从者哮喘控制和生活质量更好,直接检测高依从者血嗜酸性粒细胞水平更低。
要点
- 重症哮喘口服激素患者中依从性不佳常见,自报和直接检测均显示低依从。
- 自报与尿液检测依从性结果不一致率达53%,提示两种方法可能互补。
- 自报高依从与更好哮喘控制和生活质量相关,直接检测高依从与更低血嗜酸性粒细胞相关。
核心结论
- 低依从性是重症哮喘口服糖皮质激素患者的常见问题,无论直接检测还是自报均如此。
- 两种依从性评估方法一致性差,提示自报与规律口服激素使用之间存在分离,临床中可能提供互补信息。
研究设计与样本
- 来自U-BIOPRED研究的重症哮喘且每日处方口服糖皮质激素的参与者。
- 共纳入166例参与者数据,平均(SD)年龄54.2(±11.9)岁,FEV1占预计值65.1%(±20.5%),女性占58%。
- 参与者完成Medication Adherence Report Scale(5条目问卷,依从性评分1至5分),并提供尿液样本用液相色谱-质谱法分析泼尼松龙及其代谢物。
主要发现
- 37%完成Medication Adherence Report Scale的参与者报告依从性不佳。
- 43%有尿液糖皮质激素数据的参与者尿中未检出泼尼松龙或其代谢物。
- 在同时完成两种方法的142例参与者中,49例(35%)两种方法均检测为良好依从,53%的参与者两种方法检测结果不匹配。
- 自报高依从者哮喘控制和生活质量更好,直接检测高依从者血嗜酸性粒细胞水平更低。
临床怎么用
- 临床评估重症哮喘口服激素依从性时,可结合自报与直接检测(如尿液药物检测),因两者一致性差且可能互补。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although estimates of suboptimal adherence to oral corticosteroids in asthma range from 30% to 50%, no ideal method for measurement exists; the impact of poor adherence in severe asthma is likely to be particularly high. RESEARCH QUESTIONS: What is the prevalence of suboptimal adherence detected by self-reporting and direct measures? Is suboptimal adherence associated with disease activity? STUDY DESIGN AND METHODS: Data were included from individuals with severe asthma taking part in the U-BIOPRED (Unbiased Biomarkers for the Prediction of Respiratory Disease Outcomes) study and prescribed daily oral corticosteroids. Participants completed the Medication Adherence Report Scale, a five-item questionnaire used to grade adherence on a scale from 1 to 5, and provided a urine sample for analysis of prednisolone and metabolites by liquid chromatography-mass spectrometry. RESULTS: Data from 166 participants were included in this study: mean (SD) age, 54.2 (± 11.9) years; FEV1, 65.1% (± 20.5%) predicted; female, 58%; 37% completing the Medication Adherence Report Scale reported suboptimal adherence; and 43% with urinary corticosteroid data did not have detectable prednisolone or metabolites in their urine. Good adherence by both methods was detected in 49 of the 142 (35%) of participants in whom both methods were performed; adherence detection did not match between methods in 53%. Self-reported high adherers had better asthma control and quality of life, whereas directly measured high adherers had lower blood eosinophil levels. INTERPRETATION: Low adherence is a common problem in severe asthma, whether measured directly or self-reported. We report poor agreement between the two methods, suggesting some disassociation between self-assessment of medication adherence and regular oral corticosteroid use, which suggests that each approach may provide complementary information in clinical practice.
引用
- Alahmadi FH, Simpson AJ, Gomez C, et al. Medication Adherence in Patients With Severe Asthma Prescribed Oral Corticosteroids in the U-BIOPRED Cohort. Chest. 2021. PMID: 33610577. doi:10.1016/j.chest.2021.02.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。